Disorders of the insulin-signalling pathway are emerging as common hallmarks of both AD and DM; nevertheless, the emphasis thus far has been on T2DM, with hyperinsulinemia and insulin resistance serving as the key insults [12]. The gene discussed is INS; the disease is Alzheimer disease.